Diffusion tensor imaging with direct cytopathological validation: Characterisation of decorin treatment in experimental juvenile communicating hydrocephalus

Fluids and Barriers of the CNS

Volumn 13, Issue 1, 2016, Pages

  Aojula, Anuriti ^a,b   Botfield, Hannah ^a,b   McAllister, James Patterson ^c   Gonzalez, Ana Maria ^a   Abdullah, Osama ^d   Logan, Ann ^a,d   Sinclair, Alexandra ^a,b,e  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Birmingham Women s Hospital NHS Foundation Trust   (United Kingdom)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

^d University of Utah   (United States)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cytopathology; Decorin; DTI; Hydrocephalus

Indexed keywords

AQUAPORIN 4; COMPLEMENT RECEPTOR; DECORIN; GLIAL FIBRILLARY ACIDIC PROTEIN; KAOLIN; MYELIN BASIC PROTEIN; OX 42 COMPLEMENT RECEPTOR; UNCLASSIFIED DRUG; AQP4 PROTEIN, RAT; DCN PROTEIN, HUMAN; NEUROPROTECTIVE AGENT; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; AXIAL DIFFUSIVITY; BRAIN EDEMA; BRAIN HISTOLOGY; BRAIN VENTRICLE DILATATION; CAPSULA INTERNA; CELL DAMAGE; COMMUNICATING HYDROCEPHALUS; CONTROLLED STUDY; CORPUS CALLOSUM; CYTOPATHOLOGY; DEMYELINATION; DIFFUSION TENSOR IMAGING; EXPERIMENTAL DISEASE; FRACTIONAL ANISOTROPY; GLIOSIS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; JUVENILE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARIETAL CORTEX; PERIVENTRICULAR WHITE MATTER; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIAL DIFFUSIVITY; RAT; TREATMENT DURATION; VOXEL BASED MORPHOMETRY; WHITE MATTER; ANIMAL; ANTAGONISTS AND INHIBITORS; ATROPHY; BRAIN; CHILD; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE MODEL; DRUG EFFECTS; HYDROCEPHALUS; METABOLISM; MYELIN SHEATH; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; AQUAPORIN 4; ATROPHY; BRAIN; CHILD; DECORIN; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYDROCEPHALUS; IMMUNOHISTOCHEMISTRY; KAOLIN; MYELIN SHEATH; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; WHITE MATTER;

EID: 84975299457     PISSN: None     EISSN: 20458118     Source Type: Journal    
DOI: 10.1186/s12987-016-0033-2     Document Type: Article

References (83)

1. Fernell E, Hagberg G, Hagberg B. Infantile hydrocephalus in preterm, low-birth-weight infants-a nationwide Swedish cohort study 1979-1988. Acta Pediatr. 1993;82:45-8.
2. Simon TD, Riva-Cambrin J, Srivastava R, Bratton SL, Dean JM, Kestle JR, et al. Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths. J Neurosurg Pediatr. 2008;1:131-7.
3. Blackburn BL, Fineman RM. Epidemiology of congenital hydrocephalus in Utah, 1940-1979: report of an iatrogenically related "epidemic". Am J Med Genet. 1994;52:123-9.
4. Amlashi SF, Riffaud L, Morandi X. Communicating hydrocephalus and papilloedema associated with intraspinal tumours: report of four cases and review of the mechanisms. Acta Neurol Belg. 2006;106:31-6.
5. Cooke RS, Patterson V. Acute obstructive hydrocephalus complicating bacterial meningitis. Hydrocephalus was probably non-obstructive. BMJ. 1999;318:124.
6. Dandy WE. Intracranial tumors and abscesses causing communicating hydrocephalus. Ann Surg. 1925;82:199-207.
7. Groat J, Neumiller JJ. Review of the treatment and management of hydrocephalus. US Pharm. 2013;38:HS8-11.
8. Mirone G, Cinalli G, Spennato P, Ruggiero C, Aliberti F. Hydrocephalus and spinal cord tumors:a review. Childs Nerv Syst. 2011;27:1741-9.
9. Jung TY, Chung WK, Oh IJ. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases. Clin Neurol Neurosurg. 2014;119:80-3.
10. McAllister JP. Pathophysiology of congenital and neonatal hydrocephalus. Semin Fetal Neonatal Med. 2012;17:285-94.
11. Yang TC, Chang CH, Liu YT, Chen YL, Tu PH, Chen HC. Predictors of shunt-dependent chronic hydrocephalus after aneurysmal subarachnoid haemorrhage. Eur Neurol. 2013;69:296-303.
12. Botfield H, Gonzalez AM, Abdullah O, Skjolding AD, Berry M, McAllister JP 2nd, et al. Decorin prevents the development of juvenile communicating hydrocephalus. Brain. 2013;136:2842-58.
13. Blegvad C, Skjolding AD, Broholm H, Laursen H, Juhler M. Pathophysiology of shunt dysfunction in shunt treated hydrocephalus. Acta Neurochir (Wien). 2013;155:1763-72.
14. Harris C, McAllister JP. What we should know about the cellular and tissue response causing catheter obstruction in the treatment of hydrocephalus. Neurosurgery. 2012;70:1589-601 (discussion 1601-1602).
15. Lutz BR, Venkataraman P, Browd SR. New and improved ways to treat hydrocephalus: pursuit of a smart shunt. Surg Neurol Int. 2013;4:S38-50.
16. Pople IK. Hydrocephalus and shunts: what the neurologist should know. J Neurol Neurosurg Psychiatry. 2002;73:i17-122.
17. Dennis M, Fitz CR, Netley CT, Sugar J, Harwood-Nash DC, Hendrick EB, et al. The intelligence of hydrocephalic children. Arch Neurol. 1981;38:607-15.
18. Lacy M, Pyykkonen BA, Hunter SJ, Do T, Oliveira M, Austria E, et al. Intellectual functioning in children with early shunted posthemorrhagic hydrocephalus. Pediatr Neurosurg. 2008;44:376-81.
19. Vinchon M, Rekate H, Kulkarni AV. Pediatric hydrocephalus outcomes: a review. Fluids Barriers CNS. 2012;9:18.
20. Douglas MR, Daniel M, Lagord C, Akinwunmi J, Jackowski A, Cooper C, et al. High CSF transforming growth factor beta levels after subarachnoid haemorrhage: association with chronic communicating hydrocephalus. J Neurol Neurosurg Psychiatry. 2009;80:545-50.
21. Kaestner S, Dimitriou I. TGF beta1 and TGF beta2 and their role in posthemorrhagic hydrocephalus following SAH and IVH. J Neurol Surg A Cent Eur Neurosurg. 2013;74:279-84.
22. Kitazawa K, Tada T. Elevation of transforming growth factor-beta 1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Stroke. 1994;25:1400-4.
23. Tada T, Kanaji M, Kobayashi S. Induction of communicating hydrocephalus in mice by intrathecal injection of human recombinant transforming growth factor-beta 1. J Neuroimmunol. 1994;50:153-8.
24. Del Bigio MR, Wilson MJ, Enno T. Chronic hydrocephalus in rats and humans: white matter loss and behavior changes. Ann Neurol. 2003;53:337-46.
25. Persson EK, Hagberg G, Uvebrant P. Hydrocephalus prevalence and outcome in a population-based cohort of children born in 1989-1998. Acta Paediatr. 2005;94:726-32.
26. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biphys J. 1994;66:259-67.
27. Alexander A, Lee J, Lazar M, Field AS. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007;4:316-29.
28. Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. RSNA. 2006;26:S205-23.
29. Hasan KM, Eluvathingal TJ, Kramer LA, Ewing-Cobbs L, Dennis M, Fletcher JM. White matter microstructural abnormalities in children with spina bifida myelomeningocele and hydrocephalus: a diffusion tensor tractography study of the association pathways. J Magn Reson Imaging. 2008;27:700-9.
30. Rajagopal A, Shimony JS, McKinstry RC, Altaye M, Maloney T, Mangano FT, et al. White matter microstructural abnormality in children with hydrocephalus detected by probabilistic diffusion tractography. AJNR Am J Neuroradiol. 2013;34:2379-85.
31. Yuan W, McAllister JPI, Mangano FT. Neuroimaging of white matter abnormalities in pediatric hydrocephalus. J Pediatr Neuroradiol. 2013;2:119-28.
32. Yuan W, McKinstry RC, Shimony JS, Altaye M, Powell SK, Phillips JM, et al. Diffusion tensor imaging properties and neurobehavioral outcomes in children with hydrocephalus. AJNR Am J Neuroradiol. 2013;34:439-45.
33. Cancelliere A, Mangano FT, Air EL, Jones BV, Altaye M, Rajagopal A, et al. DTI values in key white matter tracts from infancy through adolescence. AJNR Am J Neuroradiol. 2013;34:1443-9.
34. Tuor UI, Morgunov M, Sule M, Qiao M, Clark D, Rushforth D, et al. Cellular correlates of longitudinal diffusion tensor imaging of axonal degeneration following hypoxic-ischemic cerebral infarction in neonatal rats. Neuroimage Clin. 2014;6:32-42.
35. Rossi ME, Jason E, Marchesotti S, Dastidar P, Ollikainen J, Soimakallio S. Diffusion tensor imaging correlates with lesion volume in cerebral hemisphere infarctions. BMC Med Imaging. 2010;10:21.
36. Budde MD, Xie M, Cross AH, Song SK. Axial diffusivity is the primary correlate of axonal injury in the EAE spinal cord: a quantitative pixelwise analysis. J Neurosci. 2009;29:2805-13.
37. Elshafey R, Hassanien O, Khalil M. Diffusion tensor imaging for characterizing white matter changes in multiple sclerosis. Egypt J Radiol Nucl Med. 2014;45:881-8.
38. Schmierer K, Wheeler-Kingshott CAM, Boulby PA, Scaravilli F, Altmann DR, Barker GJ, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage. 2007;35:467-77.
39. Xie M, Tobin JE, Budde MD, Chen CI, Trinkaus K, Cross AH, et al. Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features. J Neuropathol Exp Neurol. 2010;69:704-16.
40. Brennan FH, Cowin GJ, Kurniawan ND, Ruitenberg MJ. Longitudinal assessment of white matter pathology in the injured mouse spinal cord through ultra-high field (16.4 T) in vivo diffusion tensor imaging. Neuroimage. 2013;82:574-85.
41. Yuan W, Deren KE, McAllister JP 2nd, Holland SK, Lindquist DM, Cancelliere A, et al. Diffusion tensor imaging correlates with cytopathology in a rat model of neonatal hydrocephalus. Cerebrospinal Fluid Res. 2010;7:19.
42. Concha L, Livy DJ, Beaulieu C, Wheatley BM, Gross DW. In vivo diffusion tensor imaging and histopathology of the fimbria-fornix in temporal lobe epilepsy. J Neurosci. 2010;30:996-1002.
43. Goubran M, Hammond RR, de Ribaupierre S, Burneo JG, Mirsattari S, Steven DA, et al. Magnetic resonance imaging and histology correlation in the neocortex in temporal lobe epilepsy. Ann Neurol. 2015;77:237-50.
44. van Eijsden P, Otte WM, van der Hel WS, van Nieuwenhuizen O, Dijkhuizen RM, de Graaf RA, et al. In vivo diffusion tensor imaging and ex vivo histologic characterization of white matter pathology in a post-status epilepticus model of temporal lobe epilepsy. Epilepsia. 2011;52:841-5.
45. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 7th ed. London: Elsevier Inc; 2013.
46. Brouwer M, de Vries L, Pistorius L. Ultrasound measurements of the lateral ventricles in neonates: why, how and when? A systematic review. Acta Paediatr. 2010;99:1298-306.
47. Brann BS IV, et al. Asymmetric growth of the lateral cerebral ventricle in infants with posthemorrhagic ventricular dilatation. J Pediatr. 1991;118:108-12.
48. O'Hayon BB, et al. Frontal and occipital horn ratio: a linear estimate of ventricular size for multiple imaging modalities in pediatric hydrocephalus. Pediatr Neurosurg. 1998;29(5):245-9.
49. Elgamal E. Natural history of hydrocephalus in children with spinal open neural tube defect. Surg Neurol Int. 2012;3:112.
50. Missori P, Currà A. Progressive cognitive impairment evolving to dementia parallels parieto-occipital and temporal enlargement in idiopathic chronic hydrocephalus: a retrospective cohort study. Front Neurol. 2015;24(6):15.
51. McAllister JP 2nd, et al. Progression of experimental infantile hydrocephalus and effects of ventriculoperitoneal shunts: an analysis correlating magnetic resonance imaging with gross morphology. Neurosurgery. 1991;29(3):329-40.
52. Deren KE, et al. Reactive astrocytosis, microgliosis and inflammation in rats with neonatal hydrocephalus. Exp Neurol. 2010;226(1):110-9.
53. McAllister JP 2nd, et al. Differential ventricular expansion in hydrocephalus. Eur J Pediatr Surg. 1998;8(Suppl 1):39-42.
54. Assaf Y, Ben-Sira L, Constantini S, Chang LC, Beni-Adani L. Diffusion tensor imaging in hydrocephalus: initial experience. AJNR Am J Neuroradiol. 2006;27(8):1717-24.
55. Owler BK, Higgins JN, Péna A, Carpenter TA, Pickard JD. Diffusion tensor imaging of benign intracranial hypertension: absence of cerebral oedema. Br J Neurosurg. 2006;20(2):79-81.
56. Jang SH, Choi BY, Chang CH, Jung YJ, Byun WM, Kim SH, et al. The effects of hydrocephalus on the periventricular white matter in intracerebral hemorrhage: a diffuser tensor imaging study. Int J Neurosci. 2013;123:420-4.
57. Cabuk B, Etus V, Bozkurt SU, Sav A, Ceylan S. Neuroprotective effect of memantine on hippocampal neurons in infantile rat hydrocephalus. Turk Neurosurg. 2011;21:325-58.
58. Del Bigio MR, Khan OH, da Silva Lopes L, Juliet PA. Cerebral white matter oxidation and nitrosylation in young rodents with kaolin-induced hydrocephalus. J Neuropathol Exp Neurol. 2012;71:274-88.
59. Deren KE, Packer M, Forsyth J, Milash B, Abdullah OM, Hsu EW, et al. Reactive astrocytosis, microgliosis and inflammation in rats with neonatal hydrocephalus. Exp Neurol. 2010;226:110-9.
60. Eskandari R, Abdullah O, Mason C, Lloyd KE, Oeschle AN, McAllister JP 2nd. Differential vulnerability of white matter structures to experimental infantile hydrocephalus detected by diffusion tensor imaging. Childs Nerv Syst. 2014;30:1651-61.
61. Eskandari R, Harris C, McAllister J. Reactive astrocytosis in feline neonatal hydrocephalus: acute, chronic, and shunt-induced changes. Childs Nerv Syst. 2011;27:2067-76.
62. Khan OH, Enno TL, Del Bigio MR. Brain damage in neonatal rats following kaolin induction of hydrocephalus. Eep Neural. 2006;200(2):311-20.
63. Klinge PM, Samii A, Mühlendyck A, Visnyei K, Meyer GJ, Walter GF. Cerebral hypoperfusion and delayed hippocampal response after induction of adult kaolin hydrocephalus. Stroke. 2003;1:193-9.
64. Miller JM, McAllister JP 2nd. Reduction of astrogliosis and microgliosis by cerebrospinal fluid shunting in experimental hydrocephalus. Cerebrospinal Fluid Res. 2007;4:5.
65. Palazuelos J, Klingener M, Aguirre A. TGFβ signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through SMAD3/4/FoxO1/Sp1. J Neurosci. 2014;34:7917-30.
66. Dutta DJ, Zameer A, Mariani JN, Zhang J, Asp L, Huynh J, et al. Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination. Development. 2014;141:2414-28.
67. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed. 2002;15:435-55.
68. Cheong JL, Thompson DK, Wang HX, Hunt RW, Anderson PJ, Inder TE, et al. Abnormal white matter signal on MR imaging is related to abnormal tissue microstructure. AJNR Am J Neuroradiol. 2009;30:623-8.
69. Klawiter EC, Schmidt RE, Trinkaus K, Liang HF, Budde MD, Naismith RT, et al. Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. Neuroimage. 2011;55:1454-60.
70. Neil J, Miller J, Mukherjee P, Huppi PS. Diffusion tensor imaging of normal and injured developing human brain-a technical review. NMR Biomed. 2002;15:543-52.
71. Price SJ, Young AM, Scotton WJ, Ching J, Mohsen LA, Boonzaier NR, et al. Multimodal MRI can identify perfusion and metabolic changes in the invasive margin of glioblastomas. J Magn Reson Imaging. 2016;43(2):487-94 (Epub ahead of print).
72. Budde MD, Janes L, Gold E, Turtzo LC, Frank JA. The contribution of gliosis to diffusion tensor anisotropy and tractography following traumatic brain injury: validation in the rat using Fourier analysis of stained tissue sections. Brain. 2011;134:2248-60.
73. Concha L, Kim H, Bernasconi A, Bernhardt BC, Bernasconi N. Spatial patterns of water diffusion along white matter tracts in temporal lobe epilepsy. Neurology. 2012;79:455-62.
74. Filippi CG, Cauley KA. Lesions of the corpus callosum and other commissural fibers: diffusion tensor studies. Semin Ultrasound CT MR. 2014;35:445-58.
75. Hong YJ, Yoon B, Shim YS, Cho AH, Lim SC, Ahn KJ, et al. Differences in microstructural alterations of the hippocampus in Alzheimer disease and idiopathic normal pressure hydrocephalus: a diffusion tensor imaging study. AJNR Am J Neuroradiol. 2010;31:1867-72.
76. Hoza D, Vlasák A, Hořínek D, Sameš M, Alfieri A. DTI-MRI biomarkers in the search for normal pressure hydrocephalus aetiology: a review. Neurosurg Rev. 2015;38:239-44.
77. Sotak C. The role of diffusion tensor imaging in the evaluation of ischemic brain injury-a review. NMR Biomed. 2002;15:561-659.
78. Tourdias T, Dragonu I, Fushimi Y, Deloire MS, Boiziau C, Brochet B, et al. Aquaporin 4 correlates with apparent diffusion coefficient and hydrocephalus severity in the rat brain: a combined MRI-histological study. Neuroimage. 2009;47:659-66.
79. Li J, McAllister JP 2nd, Shen Y, Wagshul ME, Miller JM, Egnor MR, Johnston MG, Haacke EM, Walker ML. Communicating hydrocephalus in adult rats with kaolin obstruction of the basal cisterns or the cortical subarachnoid space. Exp Neurol. 2008;211(2):351-61.
80. Hatta J, Hatta T, Moritake K, Otani H. Heavy water inhibiting the expression of transforming growth factor-beta1 and the development of kaolin-induced hydrocephalus in mice. J Neurosurg. 2006;104(4 Suppl):251-8.
81. Slobodian I, Krassioukov-Enns D, Del Bigio MR. Protein and synthetic polymer injection for induction of obstructive hydrocephalus in rats. Cerebrospinal Fluid Res. 2007;25(4):9.
82. Sajanti J, Björkstrand AS, Finnilä S, Heikkinen E, Peltonen J, Majamaa K. Increase of collagen synthesis and deposition in the arachnoid and the dura following subarachnoid hemorrhage in the rat. Biochim Biophys Acta. 1999;1454(3):209-16.
83. Yan H, Chen Y, Li L, Jiang J, Wu G, Zuo Y, Zhang JH, Feng H, Yan X, Liu F. Decorin alleviated chronic hydrocephalus via inhibiting TGF-β1/Smad/CTGF pathway after subarachnoid hemorrhage in rats. Brain Res. 2016;1(1630):241-53.